Lv7
4940 积分 2023-01-09 加入
Antibody-drug conjugates in oncology: A spotlight on overcoming resistance
1个月前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
Rational combinations of targeted cancer therapies: background, advances and challenges
1个月前
已完结
Endogenous thymic regeneration: restoring T cell production following injury
2个月前
已完结
Abstract 4539: ZM-2311 a novel and highly potent Polθ inhibitor demonstrates synergistically anti-tumor activities in combination with different therapeutics
2个月前
已关闭
The synthesis and evaluation of a series of novel fused rings based benzothiazole derivatives as potent Polθ inhibitors
2个月前
已完结
NAD+ precursor supplementation in human ageing: clinical evidence and challenges
3个月前
已完结
Chemoproteomics-guided development of SLC15A4 inhibitors with anti-inflammatory activity
4个月前
已完结
皖公网安备34019202002308
